Steen Lisby

Sr. VP and CMO, Y-mAbs Therapeutics, Inc.

Companies

Y-mAbs Therapeutics, Inc.Sr. VP and CMO Sep 20, 2018 to Jan 22, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Y-mAbs Therapeutics, Inc.35,600 shares²Jan 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 18, 2024Granted 17,800 shares of Y-mAbs Therapeutics, Inc.²
Jan 17, 2023Granted 17,800 shares of Y-mAbs Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARY-mAbs Therapeutics, Inc., Sr. VP and CMO
2
SEC EDGARY-mAbs Therapeutics, Inc. shares after the filing of Jan 18, 2024
3
SEC EDGARForm 4 filed Jan 19, 2023